Summit Asset Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.06M | Hold |
7,706
| – | – | 0.52% | 30 |
|
|
2026
Q1 | $4.33M | Hold |
7,706
| – | – | 0.6% | 29 |
|
|
2025
Q4 | $5.21M | Sell |
7,706
-79
| -1% | -$53.8K | 0.74% | 28 |
|
|
2025
Q3 | $4.97M | Hold |
7,785
| – | – | 0.76% | 27 |
|
|
2025
Q2 | $4.18M | Hold |
7,785
| – | – | 0.68% | 29 |
|
|
2025
Q1 | $3.27M | Hold |
7,785
| – | – | 0.57% | 31 |
|
|
2024
Q4 | $3.22M | Sell |
7,785
-50
| -0.6% | -$21.9K | 0.57% | 31 |
|
|
2024
Q3 | $3.96M | Hold |
7,835
| – | – | 0.74% | 23 |
|
|
2024
Q2 | $3.82M | Hold |
7,835
| – | – | 0.79% | 22 |
|
|
2024
Q1 | $4.23M | Hold |
7,835
| – | – | 0.91% | 22 |
|
|
2023
Q4 | $4.35M | Hold |
7,835
| – | – | 1.04% | 19 |
|
|
2023
Q3 | $3.43M | Sell |
7,835
-50
| -0.6% | -$24.9K | 0.93% | 20 |
|
|
2023
Q2 | $3.96M | Hold |
7,885
| – | – | 1.04% | 19 |
|
|
2023
Q1 | $3.94M | Hold |
7,885
| – | – | 1.09% | 19 |
|
|
2022
Q4 | $3.22M | Hold |
7,885
| – | – | 0.93% | 22 |
|
|
2022
Q3 | $2.57M | Sell |
7,885
-9
| -0.1% | -$3.31K | 0.83% | 23 |
|
|
2022
Q2 | $2.77M | Hold |
7,894
| – | – | 0.86% | 23 |
|
|
2022
Q1 | $4.32M | Hold |
7,894
| – | – | 1.24% | 16 |
|
|
2021
Q4 | $5.2M | Sell |
7,894
-127
| -2% | -$79.7K | 1.47% | 13 |
|
|
2021
Q3 | $4.99M | Hold |
8,021
| – | – | 1.56% | 13 |
|
|
2021
Q2 | $5.07M | Sell |
8,021
-33
| -0.4% | -$18.2K | 1.59% | 14 |
|
|
2021
Q1 | $3.94M | Buy |
8,054
+9
| +0.1% | +$4.51K | 1.34% | 14 |
|
|
2020
Q4 | $4.02M | Sell |
8,045
-100
| -1% | -$44.7K | 1.47% | 14 |
|
|
2020
Q3 | $3.2M | Hold |
8,145
| – | – | 1.33% | 15 |
|
|
2020
Q2 | $2.69M | Hold |
8,145
| – | – | 1.22% | 15 |
|
|
2020
Q1 | $1.97M | Sell |
8,145
-100
| -1% | -$26.1K | 1.06% | 15 |
|
|
2019
Q4 | $2.15M | Hold |
8,245
| – | – | 0.92% | 16 |
|
|
2019
Q3 | $2.24M | Hold |
8,245
| – | – | 1.04% | 15 |
|
|
2019
Q2 | $2.27M | Hold |
8,245
| – | – | 1.08% | 15 |
|
|
2019
Q1 | $1.84M | Hold |
8,245
| – | – | 0.91% | 19 |
|
|
2018
Q4 | $1.53M | Hold |
8,245
| – | – | 0.87% | 19 |
|
|
2018
Q3 | $2.06M | Hold |
8,245
| – | – | 0.95% | 17 |
|
|
2018
Q2 | $1.8M | Hold |
8,245
| – | – | 0.86% | 19 |
|
|
2018
Q1 | $1.58M | Hold |
8,245
| – | – | 0.75% | 23 |
|
|
2017
Q4 | $1.29M | Sell |
8,245
-200
| -2% | -$31.5K | 0.62% | 26 |
|
|
2017
Q3 | $1.31M | Hold |
8,445
| – | – | 0.66% | 25 |
|
|
2017
Q2 | $1.36M | Hold |
8,445
| – | – | 0.72% | 25 |
|
|
2017
Q1 | $1.31M | Hold |
8,445
| – | – | 0.76% | 25 |
|
|
2016
Q4 | $990K | Sell |
8,445
-300
| -3% | -$34.2K | 0.62% | 26 |
|
|
2016
Q3 | $986K | Hold |
8,745
| – | – | 0.61% | 27 |
|
|
2016
Q2 | $812K | Sell |
8,745
-841
| -9% | -$72.2K | 0.52% | 31 |
|
|
2016
Q1 | $751K | Hold |
9,586
| – | – | 0.49% | 35 |
|
|
2015
Q4 | $699K | Hold |
9,586
| – | – | 0.47% | 35 |
|
|
2015
Q3 | $712K | Hold |
9,586
| – | – | 0.51% | 35 |
|
|
2015
Q2 | $615K | Hold |
9,586
| – | – | 0.42% | 42 |
|
|
2015
Q1 | $740K | Hold |
9,586
| – | – | 0.52% | 35 |
|
|
2014
Q4 | $711K | Hold |
9,586
| – | – | 0.51% | 33 |
|
|
2014
Q3 | $565K | Hold |
9,586
| – | – | 0.43% | 37 |
|
|
2014
Q2 | $640K | Hold |
9,586
| – | – | 0.49% | 33 |
|
|
2014
Q1 | $582K | Hold |
9,586
| – | – | 0.47% | 35 |
|
|
2013
Q4 | $510K | Buy |
9,586
+186
| +2% | +$9.79K | 0.4% | 38 |
|
|
2013
Q3 | $468K | Sell |
9,400
-400
| -4% | -$19.2K | 0.42% | 38 |
|
|
2013
Q2 | $439K | Buy |
+9,800
| New | +$428K | 0.42% | 34 |
|
Other funds holding IDXX
Summit Asset Management's IDXX Position: Q2 2026 in Review
Summit Asset Management held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 7,706 shares worth $4.06M. The position accounts for 0.52% of the portfolio, ranked #30.
Summit Asset Management first reported a position in IDXX in Q2 2013 and has held it in 53 quarters since. The position peaked at $5.21M in Q4 2025. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Summit Asset Management held 7,706 shares of Idexx Laboratories worth $4.06M as of Q2 2026.
- Summit Asset Management left its Idexx Laboratories share count unchanged in Q2 2026.
- Idexx Laboratories made up 0.52% of Summit Asset Management's portfolio in Q2 2026, its #30 holding.
- Summit Asset Management first reported a position in Idexx Laboratories in Q2 2013 and has held it in 53 quarters since.
- Summit Asset Management's Idexx Laboratories position peaked at $5.21M in Q4 2025.
- 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Summit Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.